📰 Embecta Corp News
Page 5 - Embecta Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Embecta Corp. Real-time updates on events, politics, business and more.
September 13, 2023
DUBLIN--(BUSINESS WIRE)--The "Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)), End User (Hospitals & Clinics, Patients/Homecare) - Forecast to 2028" report has been added to ResearchAndM...
September 9, 2023
Embecta Corp. (NASDAQ:EMBC – Get Free Report) Director David F. Melcher bought 6,233 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The shares were acquired at an average cost of $15.77 per share, with a total value of $98,294.41. Following the transaction, the director now owns 27,698 shares in […]
September 8, 2023
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The
September 6, 2023
PARSIPPANY, N.J., Sept. 06, 2023 -- Embecta Corp. today announced that management will participate in a fireside chat at the Morgan Stanley 21st Annual Healthcare Conference in New York on...
September 5, 2023
/PRNewswire/ -- The "Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes,...
September 5, 2023
"The prominent players operating in the global insulin delivery devices market are Embecta Corp. (Formely Becton, Dickinson and Company Diabetes Care Business (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care
August 30, 2023
Principal Financial Group Inc. lessened its position in Embecta Corp. (NASDAQ:EMBC – Free Report) by 3.3% during the first quarter, Holdings Channel reports. The institutional investor owned 353,613 shares of the company’s stock after selling 12,076 shares during the quarter. Principal Financial Group Inc.’s holdings in Embecta were worth $9,944,000 as of its most recent […]
August 24, 2023
Embecta Corp. (NASDAQ:EMBC – Get Free Report) shares gapped down prior to trading on Thursday after Morgan Stanley lowered their price target on the stock from $19.00 to $16.00. The stock had previously closed at $17.65, but opened at $17.28. Morgan Stanley currently has an underweight rating on the stock. Embecta shares last traded at […]
August 23, 2023
Embecta Corp. (NASDAQ:EMBC – Get Free Report) declared a quarterly dividend on Tuesday, August 8th, Zacks reports. Investors of record on Friday, August 25th will be given a dividend of 0.15 per share on Wednesday, September 13th. This represents a $0.60 annualized dividend and a dividend yield of 3.48%. The ex-dividend date is Thursday, August […]
August 15, 2023
Operator: Welcome, ladies and gentlemen, to the Fiscal Third Quarter 2023 Embecta Earnings Conference Call.